Adenosine-13C10
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No


Adenosine-13C10
UNSPSC Description:
Adenosine-13C10 (Adenine riboside-13C10; D-Adenosine-13C10) is 13C-labeled Adenosine (HY-B0228). Adenosine (Adenine riboside), a ubiquitous endogenous autacoid, acts through the enrollment of four G protein-coupled receptors: A1, A2A, A2B, and A3. Adenosine affects almost all aspects of cellular physiology, including neuronal activity, vascular function, platelet aggregation, and blood cell regulation.Target Antigen:
Apoptosis; Autophagy; Endogenous Metabolite; Isotope-Labeled Compounds; Nucleoside Antimetabolite/AnalogType:
Isotope-Labeled CompoundsRelated Pathways:
Apoptosis;Autophagy;Cell Cycle/DNA Damage;Metabolic Enzyme/Protease;OthersApplications:
Metabolism-protein/nucleotide metabolismField of Research:
Cancer; Metabolic DiseaseAssay Protocol:
https://www.medchemexpress.com/adenosine-13c10.htmlPurity:
99.00Solubility:
10 mM in DMSOSmiles:
N[13C]1=N[13CH]=N[13C]2=[13C]1N=[13CH]N2[13C@@H]3O[13C@H]([13CH2]O)[13C@@H](O)[13C@H]3OMolecular Weight:
277.17References & Citations:
[1]Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216.|[2]Zhou XT, et al. Inhibition of autophagy enhances adenosine induced apoptosis in human hepatoblastoma HepG2 cells. Oncol Rep. 2019;41(2):829-838.|[3]Eltzschig HK. Adenosine: an old drug newly discovered. Anesthesiology. 2009;111(4):904-915.|[4]Borea PA, Gessi S, Merighi S, Vincenzi F, Varani K. Pharmacology of Adenosine Receptors: The State of the Art. Physiol Rev. 2018;98(3):1591-1625.|[5]Fredholm BB. Adenosine, an endogenous distress signal, modulates tissue damage and repair. Cell Death Differ. 2007;14(7):1315-1323.Shipping Conditions:
Room TemperatureStorage Conditions:
-20°C, 3 years; 4°C, 2 years (Powder)Clinical Information:
No Development ReportedCAS Number:
1887761-94-5
